ID   JAK3_RAT                Reviewed;        1100 AA.
AC   Q63272; F1LR79;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   10-FEB-2021, sequence version 2.
DT   02-OCT-2024, entry version 178.
DE   RecName: Full=Tyrosine-protein kinase JAK3 {ECO:0000305};
DE            EC=2.7.10.2;
DE   AltName: Full=Janus kinase 3;
DE            Short=JAK-3;
GN   Name=Jak3 {ECO:0000312|RGD:2940};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Spleen;
RX   PubMed=8143863; DOI=10.1016/0014-5793(94)80485-0;
RA   Takahashi T., Shirasawa T.;
RT   "Molecular cloning of rat JAK3, a novel member of the JAK family of protein
RT   tyrosine kinases.";
RL   FEBS Lett. 342:124-128(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Non-receptor tyrosine kinase involved in various processes
CC       such as cell growth, development, or differentiation. Mediates
CC       essential signaling events in both innate and adaptive immunity and
CC       plays a crucial role in hematopoiesis during T-cells development. In
CC       the cytoplasm, plays a pivotal role in signal transduction via its
CC       association with type I receptors sharing the common subunit gamma such
CC       as IL2R, IL4R, IL7R, IL9R, IL15R and IL21R. Following ligand binding to
CC       cell surface receptors, phosphorylates specific tyrosine residues on
CC       the cytoplasmic tails of the receptor, creating docking sites for STATs
CC       proteins. Subsequently, phosphorylates the STATs proteins once they are
CC       recruited to the receptor. Phosphorylated STATs then form homodimer or
CC       heterodimers and translocate to the nucleus to activate gene
CC       transcription. For example, upon IL2R activation by IL2, JAK1 and JAK3
CC       molecules bind to IL2R beta (IL2RB) and gamma chain (IL2RG) subunits
CC       inducing the tyrosine phosphorylation of both receptor subunits on
CC       their cytoplasmic domain. Then, STAT5A and STAT5B are recruited,
CC       phosphorylated and activated by JAK1 and JAK3. Once activated,
CC       dimerized STAT5 translocates to the nucleus and promotes the
CC       transcription of specific target genes in a cytokine-specific fashion
CC       (By similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-
CC         [protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.10.2;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU10028};
CC   -!- SUBUNIT: Interacts with STAM2 and MYO18A (By similarity). Interacts
CC       with SHB (By similarity). Interacts with CD69 (By similarity).
CC       {ECO:0000250|UniProtKB:P52333, ECO:0000250|UniProtKB:Q62137}.
CC   -!- SUBCELLULAR LOCATION: Endomembrane system {ECO:0000250}; Peripheral
CC       membrane protein {ECO:0000250}. Cytoplasm {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: In contrast with the ubiquitous expression of the
CC       other JAKs, JAK3 is predominantly expressed in hematopoietic tissues.
CC   -!- DOMAIN: Possesses two phosphotransferase domains. The second one
CC       contains the catalytic domain, while the presence of a pseudokinase
CC       domain is required for suppression of basal activity of JAK3.
CC   -!- PTM: Autophosphorylated, leading to regulate its activity. IL2 promotes
CC       phosphorylation on tyrosine residues, including autophosphorylation on
CC       Tyr-781 (By similarity). Dephosphorylation of Tyr-976 and Tyr-977 by
CC       PTPN2 negatively regulates cytokine-mediated signaling (By similarity).
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. JAK subfamily. {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA05868.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D28508; BAA05868.1; ALT_FRAME; mRNA.
DR   EMBL; AABR07024869; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH474031; EDL90763.1; -; Genomic_DNA.
DR   EMBL; CH474031; EDL90761.1; -; Genomic_DNA.
DR   EMBL; CH474031; EDL90762.1; -; Genomic_DNA.
DR   PIR; S43677; S43677.
DR   RefSeq; NP_036987.2; NM_012855.2.
DR   RefSeq; XP_008769286.1; XM_008771064.2.
DR   AlphaFoldDB; Q63272; -.
DR   SMR; Q63272; -.
DR   STRING; 10116.ENSRNOP00000025312; -.
DR   BindingDB; Q63272; -.
DR   ChEMBL; CHEMBL4295857; -.
DR   DrugCentral; Q63272; -.
DR   iPTMnet; Q63272; -.
DR   PhosphoSitePlus; Q63272; -.
DR   PaxDb; 10116-ENSRNOP00000025312; -.
DR   Ensembl; ENSRNOT00055016295; ENSRNOP00055013095; ENSRNOG00055009634.
DR   Ensembl; ENSRNOT00060019707; ENSRNOP00060015511; ENSRNOG00060011637.
DR   Ensembl; ENSRNOT00065035477; ENSRNOP00065028582; ENSRNOG00065020890.
DR   GeneID; 25326; -.
DR   KEGG; rno:25326; -.
DR   UCSC; RGD:2940; rat.
DR   AGR; RGD:2940; -.
DR   CTD; 3718; -.
DR   RGD; 2940; Jak3.
DR   VEuPathDB; HostDB:ENSRNOG00000018669; -.
DR   eggNOG; KOG0197; Eukaryota.
DR   InParanoid; Q63272; -.
DR   OrthoDB; 1614410at2759; -.
DR   BRENDA; 2.7.10.2; 5301.
DR   Reactome; R-RNO-1266695; Interleukin-7 signaling.
DR   Reactome; R-RNO-201556; Signaling by ALK.
DR   Reactome; R-RNO-5673001; RAF/MAP kinase cascade.
DR   Reactome; R-RNO-6785807; Interleukin-4 and Interleukin-13 signaling.
DR   Reactome; R-RNO-8854691; Interleukin-20 family signaling.
DR   Reactome; R-RNO-8983432; Interleukin-15 signaling.
DR   Reactome; R-RNO-8985947; Interleukin-9 signaling.
DR   Reactome; R-RNO-9020558; Interleukin-2 signaling.
DR   Reactome; R-RNO-9020958; Interleukin-21 signaling.
DR   Reactome; R-RNO-912526; Interleukin receptor SHC signaling.
DR   PRO; PR:Q63272; -.
DR   Proteomes; UP000002494; Chromosome 16.
DR   Proteomes; UP000234681; Chromosome 16.
DR   Bgee; ENSRNOG00000018669; Expressed in thymus and 19 other cell types or tissues.
DR   GO; GO:0005856; C:cytoskeleton; IEA:InterPro.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0012505; C:endomembrane system; IEA:UniProtKB-SubCell.
DR   GO; GO:0031234; C:extrinsic component of cytoplasmic side of plasma membrane; ISO:RGD.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005131; F:growth hormone receptor binding; IBA:GO_Central.
DR   GO; GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IBA:GO_Central.
DR   GO; GO:0019903; F:protein phosphatase binding; ISO:RGD.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; ISO:RGD.
DR   GO; GO:0002250; P:adaptive immune response; IEA:UniProtKB-KW.
DR   GO; GO:0030183; P:B cell differentiation; ISS:BHF-UCL.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0007259; P:cell surface receptor signaling pathway via JAK-STAT; IBA:GO_Central.
DR   GO; GO:0071345; P:cellular response to cytokine stimulus; ISO:RGD.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; IDA:RGD.
DR   GO; GO:0007167; P:enzyme-linked receptor protein signaling pathway; ISS:BHF-UCL.
DR   GO; GO:0060397; P:growth hormone receptor signaling pathway via JAK-STAT; IBA:GO_Central.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0035723; P:interleukin-15-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0038110; P:interleukin-2-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0035771; P:interleukin-4-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0038113; P:interleukin-9-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0035556; P:intracellular signal transduction; ISS:BHF-UCL.
DR   GO; GO:0002731; P:negative regulation of dendritic cell cytokine production; ISS:BHF-UCL.
DR   GO; GO:0045221; P:negative regulation of FasL production; ISS:BHF-UCL.
DR   GO; GO:0032693; P:negative regulation of interleukin-10 production; ISS:BHF-UCL.
DR   GO; GO:0032695; P:negative regulation of interleukin-12 production; ISS:BHF-UCL.
DR   GO; GO:0050868; P:negative regulation of T cell activation; ISS:BHF-UCL.
DR   GO; GO:0045626; P:negative regulation of T-helper 1 cell differentiation; ISS:BHF-UCL.
DR   GO; GO:0070244; P:negative regulation of thymocyte apoptotic process; ISS:BHF-UCL.
DR   GO; GO:0018108; P:peptidyl-tyrosine phosphorylation; ISS:BHF-UCL.
DR   GO; GO:0042104; P:positive regulation of activated T cell proliferation; IMP:RGD.
DR   GO; GO:0051928; P:positive regulation of calcium ion transport; IMP:RGD.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IMP:RGD.
DR   GO; GO:2000670; P:positive regulation of dendritic cell apoptotic process; ISO:RGD.
DR   GO; GO:2001241; P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand; ISO:RGD.
DR   GO; GO:0051770; P:positive regulation of nitric-oxide synthase biosynthetic process; IMP:RGD.
DR   GO; GO:0042102; P:positive regulation of T cell proliferation; IDA:BHF-UCL.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0042981; P:regulation of apoptotic process; IBA:GO_Central.
DR   GO; GO:0070232; P:regulation of T cell apoptotic process; ISS:BHF-UCL.
DR   GO; GO:0070670; P:response to interleukin-4; ISO:RGD.
DR   GO; GO:0043029; P:T cell homeostasis; ISS:BHF-UCL.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; ISO:RGD.
DR   CDD; cd13334; FERM_C_JAK3; 1.
DR   Gene3D; 2.30.29.30; Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB); 1.
DR   Gene3D; 3.30.505.10; SH2 domain; 1.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 2.
DR   InterPro; IPR019749; Band_41_domain.
DR   InterPro; IPR000299; FERM_domain.
DR   InterPro; IPR041155; FERM_F1.
DR   InterPro; IPR041046; FERM_F2.
DR   InterPro; IPR051286; JAK.
DR   InterPro; IPR041381; JAK1-3/TYK2_PHL_dom.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR036860; SH2_dom_sf.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   InterPro; IPR016251; Tyr_kinase_non-rcpt_Jak/Tyk2.
DR   InterPro; IPR020775; Tyr_kinase_non-rcpt_Jak3.
DR   PANTHER; PTHR45807; TYROSINE-PROTEIN KINASE HOPSCOTCH; 1.
DR   PANTHER; PTHR45807:SF3; TYROSINE-PROTEIN KINASE JAK3; 1.
DR   Pfam; PF18379; FERM_F1; 1.
DR   Pfam; PF18377; FERM_F2; 1.
DR   Pfam; PF17887; Jak1_Phl; 1.
DR   Pfam; PF07714; PK_Tyr_Ser-Thr; 2.
DR   Pfam; PF21990; SH2_1; 1.
DR   PIRSF; PIRSF000636; TyrPK_Jak; 1.
DR   PRINTS; PR01823; JANUSKINASE.
DR   PRINTS; PR01826; JANUSKINASE3.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00295; B41; 1.
DR   SMART; SM00252; SH2; 1.
DR   SMART; SM00219; TyrKc; 2.
DR   SUPFAM; SSF50729; PH domain-like; 1.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 2.
DR   SUPFAM; SSF55550; SH2 domain; 1.
DR   PROSITE; PS50057; FERM_3; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 2.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
PE   2: Evidence at transcript level;
KW   Adaptive immunity; ATP-binding; Cytoplasm; Immunity; Innate immunity;
KW   Kinase; Membrane; Nucleotide-binding; Phosphoprotein; Reference proteome;
KW   Repeat; SH2 domain; Transferase; Tyrosine-protein kinase.
FT   CHAIN           1..1100
FT                   /note="Tyrosine-protein kinase JAK3"
FT                   /id="PRO_0000088117"
FT   DOMAIN          24..353
FT                   /note="FERM"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00084"
FT   DOMAIN          372..472
FT                   /note="SH2; atypical"
FT   DOMAIN          517..777
FT                   /note="Protein kinase 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   DOMAIN          818..1091
FT                   /note="Protein kinase 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          1..223
FT                   /note="cytokine/interferon/growth hormone receptors"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        945
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10028"
FT   BINDING         824..832
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         851
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         17
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q62137"
FT   MOD_RES         781
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P52333"
FT   MOD_RES         900
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P52333"
FT   MOD_RES         935
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P52333"
FT   MOD_RES         976
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P52333"
FT   MOD_RES         977
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P52333"
FT   CONFLICT        893
FT                   /note="S -> E (in Ref. 1; BAA05868)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        981
FT                   /note="E -> V (in Ref. 1; BAA05868)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1034
FT                   /note="M -> I (in Ref. 1; BAA05868)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1100 AA;  122726 MW;  F7FEBF8D91061C8A CRC64;
     MAPPSEETPL ISQRSCSLSS SEAGALHVLL PPRGPGPPQR LSFSFGDYLA EDLCVRAAKA
     CGILPVYHSL FALATEDLSC WFPPSHIFSI EDVDTQVLVY RLRFYFPGWF GLETCHRFGL
     HKDLTSAILD VHVLEHLFAQ HRSDLVSGRL PVGLSLKDQG EFLSLAVLDL AQMARKQAQR
     PGELLKSVSY KACLPPSLRD LIQGQSFVTR RRIRRTVVQA LRRVVACQAD RYALMAKYIL
     DLERLHPAAT TESFLVGLPG AQEEPGCLRV TGDNGIAWSS KDQELFQTFC DFPEIVDVSI
     KQAPRVGPAG EHRLVTITRM DGHILEAEFP GLPEALSFVA LVDGYFRLIC DSRHFFCKEV
     APPRLLEEEA ELCHGPITLD FAIHKLKAAG SLPGSYILRR SPQDYDSFLL TACVQTPLGP
     DYKGCLIRQD PSGAFSLVGL SQLHRSLQEL LTACWHSGLQ VDGTALNLTS CCVPRPKEKS
     NLIVVRRGRN PTPAPGHSPS CCALTKLSFH TIPADSLEWH ENLGHGSFTK IFHGHRREVV
     DGETHDTEVL LKVMDSRHQN CMESFLEAAS LMSQVSYPHL VLLHGVCMAG DSIMVQEFVY
     LGAIDTYLRK RGHLVPASWK LQVTKQLAYA LNYLEDKGLP HGNVSARKVL LAREGVDGNP
     PFIKLSDPGV SPTVLSLEML TDRIPWVAPE CLQEAGTLNL EADKWGFGAT TWEVFSGAPM
     HITSLEPAKK LKFYEDRGQL PALKWTELEG LIAQCMAYDP GRRPSFRAIL RDLNGLITSD
     YELLSDPTPG IPNPRDELCG GAQLYACQDP AIFEERHLKY ISLLGKGNFG SVELCRYDPL
     GDNTGPLVAV KQLQHSGPEQ QRDFQREIQI LKALHCDFIV KYRGVSYGPG RQSLRLVMEY
     LPSGCLRDFL QRHRARLHND RLLLFAWQIC KGMEYLGARR CVHRDLAARN ILVESEAHVK
     IADFGLAKLL PLGKDYYVVR EPGQSPIFWY APESLSDNIF SRQSDVWSFG VVLYELFTYS
     DKSCSPSTEF LRMMGPEREG SPLCHLLELL AEGRRLPPPS TCPTEVQELM QLCWSPNPQD
     RPAFDTLSPQ LDALWRGSPG
//
